Posts

Showing posts with the label GE Healthcare
Image
The global market for Diagnostic Imaging is projected to reach US$31.8 billion by 2025, driven by the importance of medical imaging in healthcare in disease prevention, early detection, diagnosis, and treatment. Essential in the management of all virtually all medical conditions and diseases, there is growing interest in R&D of newer and more powerful imaging technologies. Advanced imaging capabilities provide huge benefits such as early detection; better diagnosis; detailed visualization of anatomical structures;   easy and faster physician understanding of disease complications; better clinical decisions; reduced risk of errors; safer in terms of medical radiation exposure; and better patient outcome. Demand for diagnostic imaging services is poised to benefit from the growing global burden of disease which is directly linked to increasing life expectancy. With the average human living longer due to improvements in acute care, the risk of developing chronic diseases rem...
Image
The global market for Contrast Media is projected to reach US$5.3 billion by 2025, driven by the growing number of imaging procedures such as X-Rays, MRI, CT, and Ultrasound supported by the prevalence of chronic diseases among the growing global population and the ensuing diagnostic burden and demand for imaging services. The global burden of chronic diseases can be put into perspective by the fact that it is the leading cause of death and disability in the world. Although easily preventable, chronic diseases such as heart disease, stroke, cancer, type-2 diabetes, obesity, thyroidism, and arthritis push up healthcare costs and also demand for healthcare services. By 2030, chronic diseases will emerge to be the most costly and prevalent killer worldwide. As a result, healthcare spending is forecast to reach a mind-bending US$19 trillion by the year 2040. A major portion of this expenditure will be spent on medical imaging procedures such as X-Rays, CT scan (computed tomography sc...

Rising Incidence of Breast Cancer, Concerted Efforts Directed at Cancer Prevention & Control and Technology Migration Towards 3D Mammography to Drive the Global Mammography Equipment Market

The global market for Mammography Equipment is projected to reach US$2.2 billion by 2024 , driven by increasing patient awareness over the benefits of early breast cancer screening, rapid replacement of digital mammography systems and growing adoption of 3D mammography systems. Mammography remains the gold standard technique in breast cancer screening, driven by a combination of factors such as cost, required time for the procedure, expertise required to carry out the procedure and the test’s sensitivity and specificity rates. Growth in the market is supported by various factors including increasing patient awareness of benefits of early breast cancer screening, growing female geriatric population worldwide, rising incidence of breast cancer, continued replacement of analog systems with digital systems and accelerating adoption of 3D mammography systems. Implementation of healthcare programs by governments and organizations, especially in developing countries is expected to furth...

Robust Biosimilars Development Efforts Drives Opportunities for Tools Needed for Handling, Processing & Characterizing Biomolecules

Robustly growing Biosimilars market supported by the strong focus on reducing drug prices and cost of healthcare is poised to drive the global market for Commercial Biotechnology Separation Systems to exceed US$31.7 billion by 2024 .   Biological products are of significant importance in a wide range of sectors including food, cosmetic and pharmaceutical industries. Separating biomolecules and proteins such as RNA and DNA are key processes in commercial production of biotechnology products. These macromolecules are separated from their source material for their use in analysis as well as in production of biotechnological products. While in some applications biological products need little further processing and can be employed as crude extracts, their use in biopharmaceuticals require high levels of purity that make downstream processing with separation and purification steps critical. Separation technology is vital since it plays a major role in influencing product efficacy...